<DOC>
	<DOCNO>NCT02335580</DOCNO>
	<brief_summary>The prevalence portal vein thrombosis ( PVT ) patient liver cirrhosis 5-20 % . Current evidence regard effect portal vein thrombosis prognosis cirrhotic patient remain debate . Considering PVT potentially elevate portal pressure thereby increase risk variceal bleeding , focus patient high-risk varix variceal bleed study population . Thus , main goal analyze effect PVT incidence first variceal bleeding patient without prior bleed history high-risk varix , incidence recurrent variceal bleed patient history variceal bleeding , treatment failure rate variceal bleed patient acute variceal bleeding . Certainly , survival also observe patient .</brief_summary>
	<brief_title>Effect Portal Vein Thrombosis Prognosis Liver Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Varicose Veins</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>1 . A diagnosis liver cirrhosis . 2 . Patients diagnose highrisk varix endoscopically , prior history variceal bleeding , episode acute variceal bleeding . 3 . Patients agree undergo endoscopy evaluate presence severity varix . 4 . Patients agree undergo contrastenhanced CT scan evaluate portal vein patency . But abdominal contrastenhanced CT scan perform within 3 month admission , necessarily repeat . 1 . Noncirrhotic patient . 2 . Malignancy . 3 . Contrastenhanced CT scan neither feasible available . 4 . Severe cardiopulmonary disease . 5 . Severe infectious disease . 6 . Pregnant breastfeeding . 7 . Allergic contrast agent . 8 . Poor adherence .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Prognosis</keyword>
</DOC>